1.           Introduction

1.1       Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1           Hypothesis formulation:

3.2.2           Macroeconomic factor analysis:

3.2.3           Developing base number:

3.2.4           Data Triangulation:

3.2.5           Country-level data:

4.           Asia Pacific Human Microbiome Market – Key Market Dynamics

4.1       Market Drivers

4.1.1           Significant Investments by Key Market Players

4.1.2           Government Initiatives

4.2       Market Restraints

4.2.1           Challenges During Production of Microbiome

4.3       Market Opportunities

4.3.1           Robust Investment in Research and Development

4.4       Future Trends

4.4.1           Emergence of Precision Medicine

4.5       Impact of Drivers and Restraints:

5.           Human Microbiome Market – Asia Pacific Analysis

5.1       Asia Pacific Human Microbiome Market Revenue (US$ Million), 2021–2031

5.2       Asia Pacific Human Microbiome Market Forecast Analysis

6.           Asia Pacific Human Microbiome Market Analysis – by Type

6.1       Product

6.1.1           Overview

6.1.2           Product: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.2       Software and Services

6.2.1           Overview

6.2.2           Software and Services: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.           Asia Pacific Human Microbiome Market Analysis – by Application

7.1       Therapeutics

7.1.1           Overview

7.1.2           Therapeutics: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2       Diagnostics

7.2.1           Overview

7.2.2           Diagnostics: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.3       Research

7.3.1           Overview

7.3.2           Research: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.           Asia Pacific Human Microbiome Market Analysis – by Disease Type

8.1       Obesity

8.1.1           Overview

8.1.2           Obesity: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2       Diabetes

8.2.1           Overview

8.2.2           Diabetes: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3       Autoimmune Disorder

8.3.1           Overview

8.3.2           Autoimmune Disorder: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.4       Cancer

8.4.1           Overview

8.4.2           Cancer: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.5       GIT

8.5.1           Overview

8.5.2           GIT: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.6       Others

8.6.1           Overview

8.6.2           Others: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.           Asia Pacific Human Microbiome Market – Country Analysis

9.1       Asia Pacific

9.1.1           Asia Pacific Human Microbiome Market Overview

9.1.2           Asia Pacific Human Microbiome Market – Revenue and Forecast Analysis – by Country

9.1.2.1        Asia Pacific Human Microbiome Market – Revenue and Forecast Analysis – by Country

9.1.2.2        China: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.2.1        China: Asia Pacific Human Microbiome Market Share – by Type

9.1.2.2.2        China: Asia Pacific Human Microbiome Market Share – by Product

9.1.2.2.3        China: Asia Pacific Human Microbiome Market Share – by Application

9.1.2.2.4        China: Asia Pacific Human Microbiome Market Share – by Disease Type

9.1.2.3        Japan: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.3.1        Japan: Asia Pacific Human Microbiome Market Share – by Type

9.1.2.3.2        Japan: Asia Pacific Human Microbiome Market Share – by Product

9.1.2.3.3        Japan: Asia Pacific Human Microbiome Market Share – by Application

9.1.2.3.4        Japan: Asia Pacific Human Microbiome Market Share – by Disease Type

9.1.2.4        India: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.4.1        India: Asia Pacific Human Microbiome Market Share – by Type

9.1.2.4.2        India: Asia Pacific Human Microbiome Market Share – by Product

9.1.2.4.3        India: Asia Pacific Human Microbiome Market Share – by Application

9.1.2.4.4        India: Asia Pacific Human Microbiome Market Share – by Disease Type

9.1.2.5        Australia: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.5.1        Australia: Asia Pacific Human Microbiome Market Share – by Type

9.1.2.5.2        Australia: Asia Pacific Human Microbiome Market Share – by Product

9.1.2.5.3        Australia: Asia Pacific Human Microbiome Market Share – by Application

9.1.2.5.4        Australia: Asia Pacific Human Microbiome Market Share – by Disease Type

9.1.2.6        South Korea: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.6.1        South Korea: Asia Pacific Human Microbiome Market Share – by Type

9.1.2.6.2        South Korea: Asia Pacific Human Microbiome Market Share – by Product

9.1.2.6.3        South Korea: Asia Pacific Human Microbiome Market Share – by Application

9.1.2.6.4        South Korea: Asia Pacific Human Microbiome Market Share – by Disease Type

9.1.2.7        Rest of APAC: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.7.1        Rest of APAC: Asia Pacific Human Microbiome Market Share – by Type

9.1.2.7.2        Rest of APAC: Asia Pacific Human Microbiome Market Share – by Product

9.1.2.7.3        Rest of APAC: Asia Pacific Human Microbiome Market Share – by Application

9.1.2.7.4        Rest of APAC: Asia Pacific Human Microbiome Market Share – by Disease Type

10.        Industry Landscape

10.1     Overview

10.2     Growth Strategies in the Human Microbiome Market

10.3     Organic Growth Strategies

10.3.1         Overview

10.4     Inorganic Growth Strategies

10.4.1         Overview

11.        Company Profiles

11.1     MaaT Pharma

11.1.1         Key Facts

11.1.2         Business Description

11.1.3         Products and Services

11.1.4         Financial Overview

11.1.5         SWOT Analysis

11.1.6         Key Developments

11.2     Ferring Holdings SA

11.2.1         Key Facts

11.2.2         Business Description

11.2.3         Products and Services

11.2.4         Financial Overview

11.2.5         SWOT Analysis

11.2.6         Key Developments

11.3     AOBiome Therapeutics Inc

11.3.1         Key Facts

11.3.2         Business Description

11.3.3         Products and Services

11.3.4         Financial Overview

11.3.5         SWOT Analysis

11.3.6         Key Developments

11.4     Finch Therapeutics Group Inc

11.4.1         Key Facts

11.4.2         Business Description

11.4.3         Financial Overview

11.4.4         SWOT Analysis

11.4.5         Key Developments

11.5     Seres Therapeutics Inc

11.5.1         Key Facts

11.5.2         Business Description

11.5.3         Products and Services

11.5.4         Financial Overview

11.5.5         SWOT Analysis

11.5.6         Key Developments

11.6     Merck & Co Inc

11.6.1         Key Facts

11.6.2         Business Description

11.6.3         Products and Services

11.6.4         Financial Overview

11.6.5         SWOT Analysis

11.6.6         Key Developments

11.7     Yakult Honsha Co., Ltd.

11.7.1         Key Facts

11.7.2         Business Description

11.7.3         Products and Services

11.7.4         Financial Overview

11.7.5         SWOT Analysis

11.7.6         Key Developments

11.8     Rebiotix, Inc.

11.8.1         Key Facts

11.8.2         Business Description

11.8.3         Products and Services

11.8.4         Financial Overview

11.8.5         SWOT Analysis

11.8.6         Key Developments

11.9     IFF Nutrition & Biosciences

11.9.1         Key Facts

11.9.2         Business Description

11.9.3         Products and Services

11.9.4         Financial Overview

11.9.5         SWOT Analysis

11.9.6         Key Developments

11.10  Synthetic Biologics, Inc.

11.10.1      Key Facts

11.10.2      Business Description

11.10.3      Products and Services

11.10.4      Financial Overview

11.10.5      SWOT Analysis

11.10.6      Key Developments

12.        Appendix

12.1     Glossary of Terms

12.2     About The Insight Partners

List of Tables

Table 1.             Asia Pacific Human Microbiome Market Segmentation

Table 2.             Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3.             Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type

Table 4.             Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application

Table 5.             Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Disease Type

Table 6.             Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 7.             China: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 8.             China: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 9.             China: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 10.          China: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 11.          Japan: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 12.          Japan: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 13.          Japan: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 14.          Japan: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 15.          India: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 16.          India: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 17.          India: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 18.          India: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 19.          Australia: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 20.          Australia: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 21.          Australia: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 22.          Australia: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 23.          South Korea: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 24.          South Korea: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 25.          South Korea: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 26.          South Korea: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 27.          Rest of APAC: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 28.          Rest of APAC: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 29.          Rest of APAC: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 30.          Rest of APAC: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 31.          Recent Organic Growth Strategies in the Human Microbiome Market

Table 32.          Recent Inorganic Growth Strategies in the Human Microbiome Market

Table 33.          Glossary of Terms, Human Microbiome Market

List of Figures

Figure 1.           Asia Pacific Human Microbiome Market Segmentation – Country

Figure 2.           Asia Pacific Human Microbiome Market – Key Market Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           Asia Pacific Human Microbiome Market Revenue (US$ Million), 2021–2031

Figure 5.           Asia Pacific Human Microbiome Market Share (%) – by Type (2023 and 2031)

Figure 6.           Product: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 7.           Software and Services: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8.           Asia Pacific Human Microbiome Market Share (%) – by Application (2023 and 2031)

Figure 9.           Therapeutics: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10.        Diagnostics: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11.        Research: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12.        Asia Pacific Human Microbiome Market Share (%) – by Disease Type (2023 and 2031)

Figure 13.        Obesity: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14.        Diabetes: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15.        Autoimmune Disorder: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16.        Cancer: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17.        GIT: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18.        Others: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19.        Asia Pacific Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 20.        China: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 21.        Japan: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 22.        India: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 23.        Australia: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 24.        South Korea: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 25.        Rest of APAC: Asia Pacific Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 26.        Growth Strategies in the Human Microbiome Market